Indoco Remedies

Mumbai, India
Hybrid — also manufactures internal programs
Small Molecule API Intermediates Custom Synthesis Oral Solid Dose Topicals
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (3) ○ Clinical Trials ○ SEC Filings ✓ Press (3) ○ EMA GMP ✓ MHRA GMP (3) ✓ HC GMP (27)

Quick Facts: Indoco Remedies

Signal Score
Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters
Mumbai, India
Website
Modalities
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Indoco Remedies

Indoco Remedies makes its own pharmaceutical products and also offers contract development and manufacturing services. Capabilities: Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose, Topicals. 3 manufacturing sites registered with the U.S. FDA, the UK MHRA and Health Canada. Website: https://www.indoco.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Indoco Remedies FDA Inspection History

2025-09
2024-05
2023-02
NAI VAI OAI
Date Site Type Observations Classification
2025-09-19
Indoco Remedies Limited
Kaire Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2024-05-16
Indoco Remedies Limited
Navi Mumbai Company-level
Drug Quality Assurance No No Action Indicated (NAI)
2023-02-28
Indoco Remedies Limited
Verna Company-level
Drug Quality Assurance Yes Official Action Indicated (OAI)
Source: FDA Data Dashboard · Retrieved Oct 31, 2026

Indoco Remedies FDA 483 Findings 4 observations · 2023-02-28 → 2023-02-28 ?

By subsystem

  • Environmental Monitoring 2 (50.0%)
  • Laboratory Controls 1 (25.0%)
  • Documentation & Records 1 (25.0%)

By severity

  • 4 — Serious: 2
  • 3 — Moderate: 1
  • 2 — Minor: 1
  • Repeat observations: 0

Most severe findings

  • Serious (4) Environmental Monitoring 2023-02-28 21 CFR 211.42(c)(10)(iv)
    Environmental Monitoring System

    "Aseptic processing areas are deficient regarding the system for monitoring environmental conditions."

  • Serious (4) Environmental Monitoring 2023-02-28 21 CFR 211.42(c)(10)(vi)
    Equipment to control conditions

    "Aseptic processing areas are deficient regarding systems for maintaining any equipment used to control the aseptic conditions."

  • Moderate (3) Laboratory Controls 2023-02-28 21 CFR 211.160(b)
    Scientifically sound laboratory controls

    "Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that components conform to appropriate standards of identity, strength, quality and purity."

Indoco Remedies MHRA GMP Compliance 3 certificates

2019-05
2018-10
2018-10
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK GMP 19756 Insp GMP 19756/12594-0011[H] INDOCO REMEDIES LIMITED IN-403 722 2019-05-21 COMPLIANT
UK GMP 19756 Insp GMP 19756/617558-0006 [H] INDOCO REMEDIES LIMITED IN-173 205 2018-10-18 COMPLIANT
UK GMP 19756 Insp GMP 19756/617558-0006 [V] INDOCO REMEDIES LIMITED IN-173 205 2018-10-18 COMPLIANT
Source: MHRA GMDP Database · Retrieved Oct 31, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Oct 30, 2026

Company Signals 3 articles

Company announcements, not verified evidence. They do not change any score.
regulatory 2026-10-27
Earnings call transcript: Indoco Remedies tops INR 500 crore in Q2 2026 - Investing.com UK
Earnings call transcript: Indoco Remedies tops INR 500 crore in Q2 2026  Investing.com UK
regulatory 2026-10-26
Indoco Remedies Shares Slid Even Though It Turned A Profit - Simply Wall Street
Indoco Remedies Shares Slid Even Though It Turned A Profit  Simply Wall Street
regulatory 2026-09-29
Indoco Remedies (NSE: INDOCO) Incorporates Warren Lifesciences for Pharmaceutical Manufacturing Activities - Kalkine India
Indoco Remedies (NSE: INDOCO) Incorporates Warren Lifesciences for Pharmaceutical Manufacturing Activities  Kalkine India

Frequently Asked Questions About Indoco Remedies

How many FDA inspections does Indoco Remedies have on record?
CDMO Signal tracks 3 FDA inspections for Indoco Remedies, sourced from the FDA inspection database. See the full inspection history above.
Has Indoco Remedies received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Indoco Remedies.
Does Indoco Remedies hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 MHRA GMP certificates for Indoco Remedies.
Does Indoco Remedies have a CDMO Signal Score?
Not yet. Indoco Remedies is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Indoco Remedies for a manufacturing program?
Use the free AI matchmaker to compare Indoco Remedies against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.

Similar CDMOs

Zenji Pharmaceuticals
Huai'an, Jiangsu, China
Small Molecule API, Intermediates, Custom Synthesis, Oral Solid Dose
Divi's Laboratories
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis, Peptides
Alivus Life Sciences
Ahmedabad, India
Small Molecule API, Intermediates, Custom Synthesis
Honour Lab
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis
Hy-Gro Chemicals Pharmtek
Hyderabad, Telangana, India
Small Molecule API, Intermediates, Custom Synthesis

Compare Indoco Remedies with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Indoco Remedies
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.